8:30 a.m. – 10:00 a.m. |
Welcome & Opening General Session -
From Research to Entrepreneurship to Impact: Beyond STEM
For those of us who are not part of a STEM school or department, most of our students will never co-found a startup; so, should we care about, or teach entrepreneurship? If many investors want only to invest in technology like new drugs, devices, and other comparable products, how would entrepreneurship be achieved successfully for the social sciences? In the feverish push for new technologies to bring about economic opportunities, many of us have forgotten the essence of entrepreneurship: a risk-tolerant set of new perspectives and ways to solve problems. By doing so we have left non-STEM disciplines out of the entrepreneurship equation at universities and colleges. The reality is that nearly all big problems we face, from climate change to homelessness to disinformation on the Internet, require solutions and leadership beyond the STEM space. It is not too late to rebalance this picture. By focusing on societal impact through entrepreneurship, we can bring non-STEM researchers and students to critical roles they can, and should, play, to change the world. Come to this unique session and compare notes with leaders from social impact-focused innovation and entrepreneurship practitioners in non-STEM areas including social sciences, arts, humanities, education, and public health, and share all our experiences, tools, and resources.
|
10:30 a.m. – 11:45 a.m. |
Concurrent Sessions:
The Microbiome: Opportunities and Strategies for Technology Transfer
The microbiome is receiving increasing attention as research in the field continues to progress with commercial opportunities emerging in human health, agribusiness, and other areas. This session's panel will showcase a diverse range of opportunities that are leveraging research in this space, and will cover issues unique to the field for intellectual property protection and licensing.
Academic Venture Funds
A growing number of academic institutions are creating and deploying venture funds, or doing so collaboratively with others, to support faculty startups and other commercial enterprises bringing university technology to the market. This is a step beyond the gap funding approaches that many institutions have developed for smaller grants to faculty and students, and brings additional venture structures into the technology transfer ecosystem that are specifically geared for companies emerging from the academic environment. This session's panel will describe a variety of these funds and their approaches to supporting university spinouts.
|
12:45 p.m. – 2:00 p.m. |
Concurrent Sessions:
Biomanufacturing Facilities at Universities and Academic Medical Centers
Several institutions in the western region and across the country have developed biomanufacturing facilities that enable cell therapies, induced pluripotent stem cells, other biological materials to be produced for use in bench research, and early-stage clinical trials. This enables the institutions to significantly advance and de-risk technologies developed by their researchers, while also offering services to the community at large that can facilitate a range of collaborations, and creates a number of unique technology transfer and clinical research issues with related opportunities that will be discussed by the session's panel.
Climate Change and New Approaches to Technology Transfer
Addressing the big challenges of climate change requires big solutions. Academic research is bringing promising new advances for alternative energy and biofuels, reduction in greenhouse gases, and a host of additional applications. But, technologies in this space don’t always fit conventional technology transfer paradigms, requiring creative approaches to licensing and further developing technologies for commercial deployment. This session's panel will describe some of the efforts in this field and will cover a number of approaches used in technology transfer to structure deals with industry. |
2:15 p.m. – 3:30 p.m. |
Concurrent Sessions:
Development and Licensing of Immunotherapy Technologies
Immunotherapy has become a centerpiece of research and treatment options for patients, primarily in oncology. Academic institutions and companies located in the western region have had a leading role in this important field. This session's panel will describe some of the groundbreaking work done in the western region, a number of technology transfer challenges and successes, and what leading institutions in the field believe to be coming next.
Technology Transfer at National Labs
More than half of the Dept. of Energy’s national laboratories are located in the western region bringing important resources and capabilities to complement local academic research. This session's panel will describe the labs’ approaches to collaborating with academic institutions, the unique issues they manage from a technology transfer perspective, and the programs they contribute to the ecosystem. |